These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 20724129

  • 1. Quality of life in breast cancer patients during chemotherapy and concurrent therapy with a mistletoe extract.
    Eisenbraun J, Scheer R, Kröz M, Schad F, Huber R.
    Phytomedicine; 2011 Jan 15; 18(2-3):151-7. PubMed ID: 20724129
    [Abstract] [Full Text] [Related]

  • 2. [Efficacy and safety of long-term complementary treatment with standardized European mistletoe extract (Viscum album L.) in addition to the conventional adjuvant oncologic therapy in patients with primary non-metastasized mammary carcinoma. Results of a multi-center, comparative, epidemiological cohort study in Germany and Switzerland].
    Bock PR, Friedel WE, Hanisch J, Karasmann M, Schneider B.
    Arzneimittelforschung; 2004 Jan 15; 54(8):456-66. PubMed ID: 15460213
    [Abstract] [Full Text] [Related]

  • 3. Adjuvant intravesical treatment of superficial bladder cancer with a standardized mistletoe extract.
    Elsässer-Beile U, Leiber C, Wolf P, Lucht M, Mengs U, Wetterauer U.
    J Urol; 2005 Jul 15; 174(1):76-9. PubMed ID: 15947582
    [Abstract] [Full Text] [Related]

  • 4. Adjuvant Cancer Biotherapy by Viscum Album Extract Isorel: Overview of Evidence Based Medicine Findings.
    Sunjic SB, Gasparovic AC, Vukovic T, Weiss T, Weiss ES, Soldo I, Djakovic N, Zarkovic T, Zarkovic N.
    Coll Antropol; 2015 Sep 15; 39(3):701-8. PubMed ID: 26898069
    [Abstract] [Full Text] [Related]

  • 5. Complementary Treatment with Mistletoe Extracts During Chemotherapy: Safety, Neutropenia, Fever, and Quality of Life Assessed in a Randomized Study.
    Pelzer F, Tröger W, Nat DR.
    J Altern Complement Med; 2018 Sep 15; 24(9-10):954-961. PubMed ID: 30247950
    [Abstract] [Full Text] [Related]

  • 6. Case reports of sarcoma patients with optimized lectin-oriented mistletoe extract therapy.
    Kirsch A, Hajto T.
    J Altern Complement Med; 2011 Oct 15; 17(10):973-9. PubMed ID: 22010781
    [Abstract] [Full Text] [Related]

  • 7. Impact of complementary mistletoe extract treatment on quality of life in breast, ovarian and non-small cell lung cancer patients. A prospective randomized controlled clinical trial.
    Piao BK, Wang YX, Xie GR, Mansmann U, Matthes H, Beuth J, Lin HS.
    Anticancer Res; 2004 Oct 15; 24(1):303-9. PubMed ID: 15015612
    [Abstract] [Full Text] [Related]

  • 8. Systematic evaluation of the clinical effects of supportive mistletoe treatment within chemo- and/or radiotherapy protocols and long-term mistletoe application in nonmetastatic colorectal carcinoma: multicenter, controlled, observational cohort study.
    Friedel WE, Matthes H, Bock PR, Zänker KS.
    J Soc Integr Oncol; 2009 Oct 15; 7(4):137-45. PubMed ID: 19883529
    [Abstract] [Full Text] [Related]

  • 9. Quality of life is improved in breast cancer patients by Standardised Mistletoe Extract PS76A2 during chemotherapy and follow-up: a randomised, placebo-controlled, double-blind, multicentre clinical trial.
    Semiglazov VF, Stepula VV, Dudov A, Schnitker J, Mengs U.
    Anticancer Res; 2006 Oct 15; 26(2B):1519-29. PubMed ID: 16619567
    [Abstract] [Full Text] [Related]

  • 10. Adjuvant intravesical treatment with a standardized mistletoe extract to prevent recurrence of superficial urinary bladder cancer.
    Elsässer-Beile U, Leiber C, Wetterauer U, Bühler P, Wolf P, Lucht M, Mengs U.
    Anticancer Res; 2005 Oct 15; 25(6C):4733-6. PubMed ID: 16334168
    [Abstract] [Full Text] [Related]

  • 11. Chemotherapy versus ovarian ablation as adjuvant therapy for breast cancer: impact on health-related quality of life in a randomized trial.
    Groenvold M, Fayers PM, Petersen MA, Mouridsen HT.
    Breast Cancer Res Treat; 2006 Aug 15; 98(3):275-84. PubMed ID: 16541325
    [Abstract] [Full Text] [Related]

  • 12. Treatment of advanced pancreatic cancer with mistletoe: results of a pilot trial.
    Friess H, Beger HG, Kunz J, Funk N, Schilling M, Büchler MW.
    Anticancer Res; 1996 Aug 15; 16(2):915-20. PubMed ID: 8687151
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The impact of age on Health-Related Quality of Life (HRQoL) and symptoms among postmenopausal women with breast cancer receiving adjuvant chemotherapy.
    Browall MM, Ahlberg KM, Persson LO, Karlsson PO, Danielson EB.
    Acta Oncol; 2008 Aug 15; 47(2):207-15. PubMed ID: 18210297
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The role of health-related quality of life in early discontinuation of chemotherapy for breast cancer.
    Richardson LC, Wang W, Hartzema AG, Wagner S.
    Breast J; 2007 Aug 15; 13(6):581-7. PubMed ID: 17983400
    [Abstract] [Full Text] [Related]

  • 19. The standardised mistletoe extract PS76A2 improves QoL in patients with breast cancer receiving adjuvant CMF chemotherapy: a randomised, placebo-controlled, double-blind, multicentre clinical trial.
    Semiglasov VF, Stepula VV, Dudov A, Lehmacher W, Mengs U.
    Anticancer Res; 2004 Aug 15; 24(2C):1293-302. PubMed ID: 15154663
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.